ArticleBMC pharmacology & toxicology2026

Synergistic combination of pirfenidone and paclitaxel suppresses migration and stemness in triple-negative breast cancer: implications of EMT and pluripotency pathways.

Nima Rastegar-Pouyani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.